Clinical Trial Update: Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity [NA]

View source ↗

Summary

A clinical trial update describes monthly monitoring of plasma neurofilament light (NfL) in patients with treated relapsing-remitting multiple sclerosis to dete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Multiple Sclerosis (MS) - Relapsing-remitting | NA | Status: RECRUITING